Arrowhead Pharmaceuticals: Pay

Arrowhead Pharmaceuticals paid its 5 named executives $17.7M in total in FY2025 (Sep). CEO Christopher Anzalone was paid $9.0M of that.

Pay$100 in the stock at the end of FY20 → $80
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Christopher AnzalonePresident and Chief Executive Officer
FY2025 (Sep)
FY2024 (Sep)
FY2023 (Sep)
FY2022 (Sep)Not disclosed
FY2021 (Sep)Not disclosed
5 years
Patrick O’BrienChief Operating Officer
FY2025 (Sep)
FY2024 (Sep)
FY2023 (Sep)
FY2022 (Sep)Not disclosed
FY2021 (Sep)Not disclosed
5 years
James HamiltonChief Medical Officer
FY2025 (Sep)
FY2024 (Sep)
FY2023 (Sep)
FY2022 (Sep)Not disclosed
FY2021 (Sep)Not disclosed
5 years
Kenneth MyszkowskiFormer Chief Financial Officer
FY2025 (Sep)
FY2024 (Sep)
FY2023 (Sep)
FY2022 (Sep)Not disclosed
FY2021 (Sep)Not disclosed
5 years
Tracie OliverFormer Chief Commercial Officer
FY2025 (Sep)
FY2024 (Sep)
FY2023 (Sep)Not disclosed
FY2022 (Sep)Not disclosed
4 years

CEO pay against the pay peers

In FY2025 (Sep), the median CEO pay of the 9 peers with pay on file was $9.5M. CEO pay of Arrowhead Pharmaceuticals for that year is not on file.

  1. 1Halozyme Therapeutics
  2. 2Madrigal Pharmaceuticals
  3. 3BridgeBio Pharma
  4. 4Ionis Pharmaceuticals
  5. 5IDEAYA Biosciences
  6. 6Vir Biotechnology
  7. 7CRISPR Therapeutics AG
  8. 8Intellia Therapeutics
  9. 9Denali Therapeutics
  10. 10Arrowhead PharmaceuticalsNot disclosed
  11. 11Acadia PharmaceuticalsNot disclosed
  12. 12Amicus TherapeuticsNot disclosed
  13. 13AnaptysBioNot disclosed
  14. 14Apellis PharmaceuticalsNot disclosed
  15. 15Arcus BiosciencesNot disclosed
  16. 16Biocryst PharmaceuticalsNot disclosed
  17. 17Blueprint MedicinesNot disclosed
  18. 18Day One BiopharmacueticalsNot disclosed
  19. 19Ironwood PharmaceuticalsNot disclosed
  20. 20ProthenaNot disclosed
  21. 21Ultragenyx PharmaceuticalsNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.